- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus Lifesciences reported strong Q2 FY26 results: Revenue at Rs. 6,123.2 Cr (+17% YoY) and Net Profit at Rs. 1,258.6 Cr (+38% YoY). Performance was boosted by US/India formulations, international growth, and strategic acquisitions in Wellness & MedTech. Positive USFDA EIRs and NCE pipeline progress also noted.